1. South Korea Stocks

  2. •

    Consumer non-durables

  3. •

    Household/Personal care
Next Eye Co., Ltd.

Next Eye Co., Ltd.

KKRX:137940
1,975.00
KRW
-65.00
(-3.19%)
-4,272.57EPS
21.82BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
7,240.07
7,525.37
6,864.49
7,201.94
9,249.67
13,053.51
7,406.86
4,620.01
3,803.58
4,175.83
2,319.12
6,795.31
14,558.15
20,367.9
Basic EPS, GAAP
1,116
948
696
445.48
-283.56
-1,140
-780
5,700
-2,420
-620
-2,150
-830
-4,860
-4,130.05
Free Cash Flow per Basic Share
417.99
-483.03
262.81
257.67
-618.39
-821.22
-1,388.13
-2,928.69
-2,546.04
-627.14
-279.29
-754.09
-2,022.31
-656.45
Dividend per Share
100.01
149.98
100.12
69.79
135.49
59.91
69.65
- -
169.83
- -
- -
- -
- -
- -
Book Value per Share
8,531.02
9,352
9,948.64
10,415.85
10,093.63
10,991.62
10,517.55
15,638.39
13,782.35
13,040.69
10,988.78
10,511.6
5,142.59
6,046.38
Tangible Book Value per Share
8,298.16
9,121.26
9,788.81
10,178.06
9,444.54
10,478.52
10,095.89
15,459.67
13,189.59
12,638.99
10,452.27
10,189.88
4,936.19
5,833.56
Basic Weighted Avg Shares
4
4
4
5
6
7
8
8
8
8
8
8
8
8
Sales/Revenue/Turnover
27,906
29,162
26,566
39,342
59,483
87,219
56,098
34,793
28,692
32,196
17,749
52,035
120,063
168,449
Operating Margin (%)
19.03
12.94
10.32
10.13
2.17
9.61
-2.92
-29.76
-40.17
-10.96
-68.16
-9.77
-27.46
-15.05
Depreciation Expense
395
740
748
744
1,272
1,318
1,418
1,022
1,161
1,574
1,548
1,579
2,122
2,000
Net Income, GAAP
4,302
3,674
2,694
2,434
-1,824
-7,617
-5,908
42,926
-18,255
-4,780
-16,455
-6,356
-40,081
-34,157
Effective Tax Rate (%)
17.32
14.63
10.54
20.49
- -
- -
- -
18.41
- -
- -
- -
- -
- -
- -
Profit Margin (%)
15.41
12.6
10.14
6.19
-3.07
-8.73
-10.53
123.38
-63.62
-14.85
-92.71
-12.21
-33.38
-20.28
Working Capital
20,539
18,602
16,598
53,212
58,922
88,743
60,585
82,121
54,497
51,278
37,683
34,583
2,394
9,519
LT Debt
3,000
1,687
937
20,608
34,064
23,524
1,372
38
1,338
1,369
177
516
352
330
Total Equity
33,681
36,677
38,702
65,432
75,286
118,773
111,854
120,626
105,653
100,741
83,602
79,507
39,879
47,695
Return on Invested Capital (%)
13.12
8.46
6.22
5.01
- -
- -
- -
-5.53
- -
- -
- -
- -
- -
- -
Return on Capital (%)
13.15
10.26
6
2.8
- -
- -
- -
29.7
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
13.92
10.6
7.26
4.94
-2.85
-10.14
-7.29
43.56
-16.35
-4.66
-17.89
-7.72
-64.92
-50.48

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
15,217
15,956
15,778
LT Borrowings
- -
- -
- -
LT Finance Leases
438
352
330
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
8
8
Market Capitalization
28,678
26,003
21,822

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
62,087
56,277
66,941
Cash, Cash Equivalents & STI
29,785
31,627
36,892
Accounts Receivable, Net
2,861
1,002
3,884
Inventories
9,937
9,831
9,272
Total Current Liabilities
38,780
53,882
57,422
Payables & Accruals
- -
- -
- -
ST Debt
15,217
15,956
15,778
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.51%
-17.76%
-49.84%
Free Cash Flow
11.07%
43.09%
188.83%
Net Income, GAAP
-21.88%
99.43%
530.63%
Sales/Revenue/Turnover
34.6%
54.74%
130.74%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7,169
30,067
2,423
12,375
52,035
2025
5,767
16,405
44,125
53,766
120,063
2026
54,152
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-160
-30
-680
43.45
-830
2025
200
294.59
-2,273.32
-3,037.07
-4,860
2026
898.9
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Guang Chen
Full Time Employees
27
Sector
Consumer non-durables
Industry
Household/Personal care
Address
Anyang-si South Korea
IPO Date
Jun 14, 2011
Website
nexteye.com
Similar Companies
Procter & Gamble Company (The) (NYSE:PG)
Cupid Limited (NSE:CUPID)
Hindustan Unilever Limited (NSE:HINDUNILVR)
Colgate-Palmolive (India) Limited (NSE:COLPAL)
Dabur India Limited (NSE:DABUR)
e.l.f. Beauty, Inc. (NYSE:ELF)
Business
Next Eye Co., Ltd. is a South Korea-based technology and distribution enterprise primarily engaged in the development and manufacture of machine vision inspection systems, alongside the international distribution of cosmetics, bio-healthcare products, and consumer goods. The company delivers specialized industrial solutions and commercial offerings comprising: automated optical inspection equipment for polarizing films; flat panel display and glass inspection systems; backlight unit defect detection devices; printed circuit board optical testing equipment; mobile handset assembly and dimensional inspection modules; non-destructive X-ray foreign material inspection systems for food, pharmaceutical, and industrial packaging; secondary battery and power battery cell inspection systems; proprietary machine vision algorithms and image processing software; skincare, cosmetics, and beauty care instruments; beauty salon franchising and technical training services; and cross-border business-to-consumer e-commerce retail operations supplying bio-healthcare formulations and anti-aging dietary supplements, including IONA GENEAKG. Founded in 1998 and headquartered in Anyang-si, Gyeonggi-do, South Korea, Next Eye Co., Ltd. serves electronics manufacturers, industrial processors, and consumer retail markets across South Korea, China, Taiwan, Vietnam, and the United States, operating key subsidiaries including U.S.-based Rodmir Bio and technology affiliate Mindseye. In recent developments, the company has undertaken a strategic expansion into global direct-to-consumer healthcare e-commerce through its Rodmir platform, scaling distribution across eleven countries and achieving record consolidated revenues; completed a reverse stock split and capital restructuring to adjust its share base on the KOSDAQ market; and resolved capital increase measures through rights offerings to support ongoing international commercial expansion.